Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening and Management of Cardiovascular Risk in Belgian Women Aged > or = 65 Years With Metastatic Breast Cancer Before and After Anthracycline Treatment

NCT01555944 is registered in ClinicalTrials.gov with Teva Pharma as lead sponsor.

NCT NCT01555944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01555944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening and Management of Cardiovascular Risk in Belgian Women Aged > or = 65 Years With Metastatic Breast Cancer Before and After Anthracycline Treatment
Lead sponsor
Teva Pharma
Phase
Observational
Overall status
Completed
Start date
February 29, 2012
Completion date
April 30, 2016
Enrollment
60 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer